FDA issues public health advisory on NEJM report

Share this article:
The FDA will issue a public health advisory based on a June 8 New England Journal of Medicine report of an increased risk of birth defects when women take ACE inhibitors during the first trimester of pregnancy. The FDA says women should stop using them as soon as possible after pregnancy is detected.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Legal/Regulatory

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.